Fibrates and Diabetic Outcomes

Thomas Dayspring discusses the impact of fibrates on diabetic outcomes, highlighting their potential to reduce microvascular endpoints and improve renal disease. He argues that fibrates should be considered as a treatment option for diabetics, especially those with hypertriglyceridemia.